N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an α7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate

被引：15
|
作者：
Zanaletti, Riccardo [1 ]
Bettinetti, Laura [1 ]
Castaldo, Cristiana [1 ]
Ceccarelli, Ilaria [1 ]
Cocconcelli, Giuseppe [1 ]
Comery, Thomas A. [2 ]
Dunlop, John [2 ]
Genesio, Eva [1 ]
Ghiron, Chiara [1 ]
Haydar, Simon N. [2 ]
Jow, Flora [2 ]
Maccari, Laura [1 ]
Micco, Iolanda [1 ]
Nencini, Arianna [1 ]
Fratelli, Carmela [1 ]
Scali, Carla [1 ]
Turlizzi, Elisa [1 ]
Valacchi, Michela [1 ]
机构：
[1] Siena Biotech SpA, I-53100 Siena, Italy
[2] Pfizer Inc, Neurosci Res Unit, Groton, CT 06340 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2012年 / 55卷 / 22期
关键词：
DISCOVERY; SCHIZOPHRENIA; RAT;
D O I：
10.1021/jm3013568
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
alpha 7 nicotinic acetylcholine receptors (alpha 7 nAChR) represent promising therapeutic candidates for the treatment of cognitive impairment, associated with Alzheimer's disease (AD) and schizophrenia. A medicinal chemistry effort around previously reported compound 1 (SEN15924, WAY 361789) led to the identification of 12 (SEN78702, WYE-308775) a potent and selective full agonist of the alpha 7 nAChR that demonstrated improved plasma stability, brain levels, and efficacy in behavioral cognition models.
引用
收藏
页码：10277 / 10281
页数：5
相关论文
共 50 条
  • [41] Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl) piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
    Jiang, Xueyang
    Liu, Chang
    Zou, Manxing
    Xie, Huanfang
    Lin, Tailiang
    Lyu, Weiping
    Xu, Jian
    Li, Yuan
    Feng, Feng
    Sun, Haopeng
    Liu, Wenyuan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 223
  • [42] N-[3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl]-4-fluorobenzamide:: A potent, selective, and orally active 5-HT1F receptor agonist potentially useful for migraine therapy
    Xu, YC
    Johnson, KW
    Phebus, LA
    Cohen, M
    Nelson, DL
    Schenck, K
    Walker, CD
    Fritz, JE
    Kaldor, SW
    LeTourneau, ME
    Murff, RE
    Zgombick, JM
    Calligaro, DO
    Audia, JE
    Schaus, JM
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) : 4031 - 4034
  • [43] Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl)}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2
    Thomas, James B.
    Vivancos, Melanie
    Giddings, Angela M.
    Wiethe, Robert W.
    Warner, Keith R.
    Murza, Alexandre
    Besserer-Offroy, Elie
    Longpre, Jean-Michel
    Runyon, Scott P.
    Decker, Ann M.
    Gilmour, Brian P.
    Sarret, Philippe
    ACS CHEMICAL NEUROSCIENCE, 2016, 7 (09): : 1225 - 1231
  • [44] Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the α7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia:: Synthesis and structure-activity relationship
    Wishka, Donn G.
    Walker, Daniel P.
    Yates, Karen M.
    Reitz, Steven C.
    Jia, Shaojuan
    Myers, Jason K.
    Olson, Kirk L.
    Jacobsen, E. Jon
    Wolfe, Mark L.
    Groppi, Vincent E.
    Hanchar, Alexander J.
    Thornburgh, Bruce A.
    Cortes-Burgos, Luz A.
    Wong, Erik H. F.
    Staton, Brian A.
    Raub, Thomas J.
    Higdon, Nicole R.
    Wall, Theron M.
    Hurst, Raymond S.
    Walters, Rodney R.
    Hoffmann, William E.
    Hajos, Mihaly
    Franklin, Stanley
    Carey, Galen
    Gold, Lisa H.
    Cook, Karen K.
    Sands, Steven B.
    Zhao, Sabrina X.
    Soglia, John R.
    Kalgutkar, Amit S.
    Arneric, Stephen P.
    Rogers, Bruce N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4425 - 4436
  • [45] Synthesis of 1-(2,4-dichlorophenyl)-4-cyano-5-(4[11C]methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide ([11C]JHU75528) and 1-(2bromophenyl)-4-cyano-5-(4-[11C]methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide ([11C]JHU75575) as potential radioligands for PET imaging of cerebral cannabinoid receptor
    Fan, Hong
    Ravert, Hayden T.
    Holt, Daniel P.
    Dannals, Robert F.
    Horti, Andrew G.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (12): : 1021 - 1036
  • [46] Identification of the Clinical Candidate (R)-(1-(4-Fluoropheny1)-6-((1methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist
    Hunt, Hazel J.
    Belanoff, Joseph K.
    Walters, Iain
    Gourdet, Benoit
    Thomas, Jennifer
    Barton, Naomi
    Unitt, John
    Phillips, Timothy
    Swift, Denise
    Eaton, Emily
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (08) : 3405 - 3421
  • [47] Structure-Based Drug Discovery of N-((R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(((S)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2′-oxo-1′,2′-dihydrospiro[piperidine-4,4′-pyrido[2,3-d][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of Migraine
    Bucknell, Sarah J.
    Ator, Mark A.
    Brown, Alastair J. H.
    Brown, Jason
    Cansfield, Andrew D.
    Cansfield, Julie E.
    Christopher, John A.
    Congreve, Miles
    Cseke, Gabriella
    Deflorian, Francesca
    Jones, Christopher R.
    Mason, Jonathan S.
    O'Brien, M. Alistair
    Ott, Gregory R.
    Pickworth, Mark
    Southall, Stacey M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (14) : 7906 - 7920
  • [48] Synthesis of Substituted -N-(5-((7-Methyl-2-Oxo-2H-Chromen-4-yl)-Methyl)-1,3,4-Thiadiazol-2-yl)-Benzamide Derivatives Using TBTU as Coupling Agent and their Evaluation for Anti Tubercular Activity
    Kakadiya, Monika
    Pasha, Yunus
    Noolvi, Malleshappa
    Patel, Ashish
    LETTERS IN ORGANIC CHEMISTRY, 2022, 19 (02) : 158 - 166
  • [49] In Vitro Pharmacological Characterization of a Novel Allosteric Modulator of α7 Neuronal Acetylcholine Receptor, 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), Exhibiting Unique Pharmacological Profile
    Malysz, John
    Gronlien, Jens Halvard
    Anderson, David J.
    Hakerud, Monika
    Thorin-Hagene, Kirsten
    Ween, Hilde
    Wetterstrand, Caroline
    Briggs, Clark A.
    Faghih, Ramin
    Bunnelle, William H.
    Gopalakrishnan, Murali
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01): : 257 - 267
  • [50] Crystal structure of N-((3-cyano-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(2,2,2-trifluoroacetyl)-1H-pyrazol-5-yl)carbamoyl)-2,6-difluorobenzamide, C20H7Cl2F8N5O3S
    Fang, Yingchun
    Song, Changlei
    Duan, Yu-e
    Xie, Xiaoxue
    Du, Qingbo
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2025,
12345